The impacts of COVID-19 vaccine timing, number of doses, and risk prioritization on mortality in the US
| dc.creator | Wang, Xutong | |
| dc.creator | Du, Zhanwei | |
| dc.creator | Johnson, Kaitlyn E. | |
| dc.creator | Pasco, Remy | |
| dc.creator | Fox, Spencer J. | |
| dc.creator | Lachmann, Michael | |
| dc.creator | McLellan, Jason S. | |
| dc.creator | Meyers, Lauren Ancel | |
| dc.date.accessioned | 2024-07-29T20:41:23Z | |
| dc.date.available | 2024-07-29T20:41:23Z | |
| dc.date.issued | 2021-02 | |
| dc.description.abstract | As COVID-19 vaccination begins worldwide, policymakers face critical trade-offs. Using a mathematical model of COVID-19 transmission, we find that timing of the rollout is expected to have a substantially greater impact on mortality than risk-based prioritization and uptake and that prioritizing first doses over second doses may be life saving. | |
| dc.description.department | Molecular Biosciences | |
| dc.description.department | Integrative Biology | |
| dc.description.sponsorship | This research was supported by NIH Grant R01 AI151176 and CDC Grant U01 IP00136. | |
| dc.identifier.doi | 10.1101/2021.01.18.21250071 | |
| dc.identifier.uri | https://hdl.handle.net/2152/126215 | |
| dc.identifier.uri | https://doi.org/10.26153/tsw/52752 | |
| dc.rights | Attribution NonCommercial 4.0 International | |
| dc.rights.uri | https://creativecommons.org/licenses/by-nc/4.0/deed.en | |
| dc.source.uri | https://www.medrxiv.org/content/10.1101/2021.01.26.21250065v1 | |
| dc.subject | COVID-19 | |
| dc.subject | vaccine timing | |
| dc.subject | risk prioritization | |
| dc.subject | U.S. | |
| dc.title | The impacts of COVID-19 vaccine timing, number of doses, and risk prioritization on mortality in the US | |
| dc.type | Pre-print |